help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2007.061144 on November 30, 2007

Published online before print November 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2007.061144v1
171/6/2021    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnold, R. S.
Right arrow Articles by Petros, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnold, R. S.
Right arrow Articles by Petros, J. A.
(American Journal of Pathology. 2007;171:2021-2032.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.061144

Nox1 Expression Determines Cellular Reactive Oxygen and Modulates c-fos-Induced Growth Factor, Interleukin-8, and Cav-1

Rebecca S. Arnold*{dagger}, Ju He*, Andrea Remo*{ddagger}, Darren Ritsick{ddagger}, Qiqin Yin-Goen{ddagger}§, J. David Lambeth{ddagger}, Milton W. Datta*{ddagger}, Andrew N. Young{ddagger}§ and John A. Petros*{dagger}{ddagger}§

From the Departments of Urology,* Pathology,{ddagger} and Laboratory Medicine,{dagger} Winship Cancer Institute, Emory University School of Medicine, Atlanta; and the Atlanta Veterans Administration Medical Center,§ Decatur, Georgia

Increased cellular reactive oxygen species (ROS) can act as mitogenic signals in addition to damaging DNA and oxidizing lipids and proteins, implicating ROS in cancer development and progression. To analyze the effects of Nox1 expression and its relation to cellular ROS and signal transduction involved in cellular proliferation, Nox1RNAi constructs were transfected into DU145 prostate cancer cells overexpressing Nox1, causing decreased Nox1 message and protein levels in the Nox1RNAi cell lines. Increased ROS and tumor growth in the Nox1-overexpressing DU145 cells were reversed in the presence of the Nox1RNAi. Analysis and comparison of the message levels in the overexpression and RNAi cells demonstrated that Nox1 overexpression leads to changes in message levels of a variety of proteins including c-fos-induced growth factor, interleukin-8, and Cav-1. Finally, we found that Nox1 protein overexpression is an early event in the development of prostate cancer using a National Cancer Institute prostate cancer tissue microarray (CPCTR). Tumor (86%) was significantly more likely to have Nox1 staining than benign prostate tissue (62%) (P = 0.0001). These studies indicate that Nox1 overexpression may function as a reversible signal for cellular proliferation with relevance for a common human tumor.





This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Shimada, M. Nakamura, S. Anai, M. De Velasco, M. Tanaka, K. Tsujikawa, Y. Ouji, and N. Konishi
A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression
Cancer Res., April 1, 2009; 69(7): 3157 - 3164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.